Valuation: SPINEWAY

Market Cap 2.63M 3M 2.43M 2.24M 4.23M 290M 4.29M 29.1M 11.4M 142M 11.28M 11.03M 488M P/E 2026 *
-1.89x
P/E 2027 * -1.89x
Enterprise Value 9.13M 10.42M 8.45M 7.76M 14.67M 1.01B 14.89M 101M 39.55M 492M 39.14M 38.27M 1.69B EV / Sales 2026 *
0.69x
EV / Sales 2027 * 0.97x
Free-Float
9.65%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 65 2005-09-27
Director of Finance/CFO - 2024-10-31
Director TitleAgeSince
Chairman 65 2005-09-27
Director/Board Member 48 2017-10-12
Director/Board Member 46 2016-04-25
Change 5-day change 1-year change 3-year change Capi.($)
+0.97%+8.23%-17.80%-5.24% 175B
+0.11%-0.69%-7.05%-3.29% 106B
-1.27%+0.18%+3.80%+58.38% 59.91B
+0.66%+0.96%+37.64%+54.22% 51.95B
-2.33%+1.67%-13.63%-39.40% 43.58B
-2.29%-5.26% - - 33.65B
-1.25%+0.97%-9.77%-43.36% 29.58B
-1.65%-0.39%+67.06%-8.64% 25.31B
-1.55%-0.71%-4.93%-5.70% 21.23B
Average -0.96%+1.58%+6.92%+0.87% 60.79B
Weighted average by Cap. -0.27%+2.75%-1.91%+3.32%

Financials

2026 *2027 *
Net sales 13.2M 15.07M 12.21M 11.22M 21.21M 1.45B 21.53M 146M 57.17M 711M 56.57M 55.32M 2.45B 14.5M 16.55M 13.41M 12.32M 23.29M 1.6B 23.65M 160M 62.8M 781M 62.14M 60.77M 2.69B
Net income -2.5M -2.85M -2.31M -2.12M -4.02M -275M -4.08M -27.64M -10.83M -135M -10.71M -10.48M -464M -2.5M -2.85M -2.31M -2.12M -4.02M -275M -4.08M -27.64M -10.83M -135M -10.71M -10.48M -464M
Net Debt 6.5M 7.42M 6.01M 5.52M 10.44M 716M 10.6M 71.85M 28.15M 350M 27.86M 27.24M 1.21B 11.4M 13.01M 10.54M 9.69M 18.31M 1.26B 18.59M 126M 49.37M 614M 48.85M 47.78M 2.11B
Logo SPINEWAY
Spineway designs, produces, and sells spinal column implants and surgical instruments. The group offers spinal systems, cervical and lumbar cages, cervical plates, bone substitutes, etc. Net sales are distributed geographically as follows: France (24.4%), Europe (16.9%), Latin America (34.3%), Asia (18.2%) and the Middle East and Africa (6.2%).
Employees
-